As human AD-associated abnormalities in insulin and IGF-1 signaling are highly reminiscent of type 1 and type 2 diabetes mellitus, though they selectively involve the brain, de la Monte and colleagues have called AD ‘type 3 diabetes’ [85,131,132,133]. This evidence concerns the gene IGF1 and Alzheimer disease.